Researchmoz added Most up-to-date research on "Global Central Nervous System Disorders Therapeutics Market 2016-2020" to its huge collection of research reports.
CNS disorders can affect either the brain or spinal cord, or both. CNS disorders are also called as neurological and psychiatric disorders. The major causes of CNS disorders are infections, trauma, degeneration, structural defects, tumors, autoimmune disorders, and stroke. A headache, muscle weakness, memory loss, impaired mental ability, and lack of coordination are few of the symptoms of CNS disorders.
Technavios analysts forecast the global central nervous system (CNS) disorders therapeutics market to grow at a CAGR of 3.38% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global central nervous system (CNS) disorders therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-labeled drugs used for the treatment of various CNS disorders including bipolar disorders, depression, epilepsy, PD, AD, Huntington's disease (HD), multiple sclerosis (MS), schizophrenia, attention-deficit hyperactivity disorder (ADHD), migraine, and anxiety.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=825407
Technavio's report, Global Central Nervous System (CNS) Disorders Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
GlaxoSmithKline
Pfizer
Eli Lilly
Janssen Pharmaceuticals
Novartis
Other prominent vendors
AB Science
AbbVie
Abital Pharma
Acorda Therapeutics
Active Biotech
Adamas Pharmaceuticals
Addex Therapeutics
Akorn
Alcobra
Alexza Pharmaceuticals
Alkermes
Amarantus
Aprecia Pharmaceuticals
Archer Pharmaceuticals
Astellas
AstraZeneca
Aurobindo Pharma
Auspex Pharmaceuticals
Avanir Pharmaceuticals
Biscayne Pharmaceuticals
Boehringer Ingelheim
Cerecor
Concordia
Convergence Pharmaceuticals
Curemark
CURx Pharmaceuticals
Dainippon Sumitomo Pharma
Dart NeuroScience
Delpor
Desitin Arzneimittel
D-Pharm
Edgemont Pharmaceuticals
Endo International
E-Therapeutics
Euthymics
Evotec
F. Hoffmann-La Roche
Fabre-Kramer Pharmaceuticals
Forum Pharmaceuticals
Gedeon Richter
Glenmark
Grupo Ferrer Internacional
GW Pharmaceuticals
H. Lundbeck
Hisamitsu
Impax
Insero Health
INSYS Therapeutics
Intellipharmaceutics
Intra-Cellular Therapies
Ipsen
Kyowa Hakko Kirin
Ligand Pharmaceuticals
Lupin
MarcoPolo Pharmaceuticals
Marinus Pharmaceuticals
Meda AB
Merck
Mitsubishi Tanabe
MSI Methylation Sciences
Mylan
Naurex
Neuralstem
Neurelis
Neurovance
Nobelpharma
Noven Pharmaceuticals
Omeros
Opexa
Opko Health
Orion
Ophelia Pharmaceutical
Otsuka Pharmaceuticals
Palobiofarma
Par Pharmaceuticals
Pierre Fabre
Prana Biotechnology
Raptor Pharmaceutical
Reviva Pharmaceuticals
SAGE Therapeutics
Sanofi
SciFlour
Sedor Pharmaceuticals
Shire
Siena Biotech
SK Biopharmaceuticals
SOM Biotech
Somerset Pharmaceuticals
STADA Arzneimittel
Sun Pharmaceuticalc
Sunovion Pharmaceuticals
Supernus Pharmaceuticals
Suven
Takeda Pharmaceuticals
Teva Pharmaceuticals
Torrent Pharmaceuticals
Tris Pharma
Turing Pharmaceuticals
UCB
US WorldMeds
Valeant Pharmaceuticals
Zinfandel Pharmaceuticals
Zogenix
Market driver
New DMD approvals for AD, PD, and MS
For a full, detailed list, view our report
Market challenge
High failure rates of late-stage products in clinical trials
For a full, detailed list, view our report
Market trend
Increased uptake of new-generation drugs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=825407
CNS disorders can affect either the brain or spinal cord, or both. CNS disorders are also called as neurological and psychiatric disorders. The major causes of CNS disorders are infections, trauma, degeneration, structural defects, tumors, autoimmune disorders, and stroke. A headache, muscle weakness, memory loss, impaired mental ability, and lack of coordination are few of the symptoms of CNS disorders.
Technavios analysts forecast the global central nervous system (CNS) disorders therapeutics market to grow at a CAGR of 3.38% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global central nervous system (CNS) disorders therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-labeled drugs used for the treatment of various CNS disorders including bipolar disorders, depression, epilepsy, PD, AD, Huntington's disease (HD), multiple sclerosis (MS), schizophrenia, attention-deficit hyperactivity disorder (ADHD), migraine, and anxiety.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=825407
Technavio's report, Global Central Nervous System (CNS) Disorders Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
GlaxoSmithKline
Pfizer
Eli Lilly
Janssen Pharmaceuticals
Novartis
Other prominent vendors
AB Science
AbbVie
Abital Pharma
Acorda Therapeutics
Active Biotech
Adamas Pharmaceuticals
Addex Therapeutics
Akorn
Alcobra
Alexza Pharmaceuticals
Alkermes
Amarantus
Aprecia Pharmaceuticals
Archer Pharmaceuticals
Astellas
AstraZeneca
Aurobindo Pharma
Auspex Pharmaceuticals
Avanir Pharmaceuticals
Biscayne Pharmaceuticals
Boehringer Ingelheim
Cerecor
Concordia
Convergence Pharmaceuticals
Curemark
CURx Pharmaceuticals
Dainippon Sumitomo Pharma
Dart NeuroScience
Delpor
Desitin Arzneimittel
D-Pharm
Edgemont Pharmaceuticals
Endo International
E-Therapeutics
Euthymics
Evotec
F. Hoffmann-La Roche
Fabre-Kramer Pharmaceuticals
Forum Pharmaceuticals
Gedeon Richter
Glenmark
Grupo Ferrer Internacional
GW Pharmaceuticals
H. Lundbeck
Hisamitsu
Impax
Insero Health
INSYS Therapeutics
Intellipharmaceutics
Intra-Cellular Therapies
Ipsen
Kyowa Hakko Kirin
Ligand Pharmaceuticals
Lupin
MarcoPolo Pharmaceuticals
Marinus Pharmaceuticals
Meda AB
Merck
Mitsubishi Tanabe
MSI Methylation Sciences
Mylan
Naurex
Neuralstem
Neurelis
Neurovance
Nobelpharma
Noven Pharmaceuticals
Omeros
Opexa
Opko Health
Orion
Ophelia Pharmaceutical
Otsuka Pharmaceuticals
Palobiofarma
Par Pharmaceuticals
Pierre Fabre
Prana Biotechnology
Raptor Pharmaceutical
Reviva Pharmaceuticals
SAGE Therapeutics
Sanofi
SciFlour
Sedor Pharmaceuticals
Shire
Siena Biotech
SK Biopharmaceuticals
SOM Biotech
Somerset Pharmaceuticals
STADA Arzneimittel
Sun Pharmaceuticalc
Sunovion Pharmaceuticals
Supernus Pharmaceuticals
Suven
Takeda Pharmaceuticals
Teva Pharmaceuticals
Torrent Pharmaceuticals
Tris Pharma
Turing Pharmaceuticals
UCB
US WorldMeds
Valeant Pharmaceuticals
Zinfandel Pharmaceuticals
Zogenix
Market driver
New DMD approvals for AD, PD, and MS
For a full, detailed list, view our report
Market challenge
High failure rates of late-stage products in clinical trials
For a full, detailed list, view our report
Market trend
Increased uptake of new-generation drugs
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=825407
No comments:
Post a Comment